Chai Discovery

“Chai Discovery...develops AI models that help drugmakers design molecules by predicting and reprogramming how molecules interact, raised a $400 million round at a $3.8 billion post-money valuation.”

“San Francisco-based Chai Discovery, which builds AI models for molecular drug design, raised a $400 million Series C led by Index Ventures, Kleiner Perkins and Sequoia Capital at a $3.8 billion valuation.”